Страна: Ірландія
мова: англійська
Джерело: HPRA (Health Products Regulatory Authority)
ZOLPIDEM TARTRATE
Imbat Limited
N05CF; N05CF02
ZOLPIDEM TARTRATE
10 milligram(s)
Film-coated tablet
Product subject to prescription which may not be renewed (A)
Benzodiazepine related drugs; zolpidem
Authorised
2007-05-04
Page 1 of 2 PACKAGE LEAFLET: INFORMATION FOR THE PATIENT STILNOCT ® 10MG FILM-COATED TABLETS (zolpidem tartrate) Blind or partially sighted? Is this leaflet hard to see or read? Call +44 (0) 1302 365000 (Regulatory) Please be ready to give the following information: Product name: Stilnoct 10mg Film-Coated Tablets Reference No: PPA1151/030/001 Your medicine is imported from the UK under the name of ‘Zolpidem Tartrate 10mg Tablets’ but is marketed as ‘Stilnoct 10mg Film-Coated Tablets’ in Ireland. Your medicine is available using the above name but will be referred to as Stilnoct throughout this leaflet. READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. Keep this leaflet. You may need to read it again. If you have any further questions, ask your doctor or pharmacist. This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See Section 4. WHAT IS IN THIS LEAFLET: 1. What Stilnoct is and what it is used for 2. What you need to know before you take Stilnoct 3. How to take Stilnoct 4. Possible side effects 5. How to store Stilnoct 6. Contents of the pack and other information 1. WHAT STILNOCT IS AND WHAT IT IS USED FOR The name of your medicine is Stilnoct. The tablets come in two strengths: Stilnoct 5mg Tablets and Stilnoct 10mg Tablets. Zolpidem tartrate belongs to a group of medicines called hypnotics. It works by acting on your brain to help you sleep. Stilnoct is used for temporary sleep problems in adults that are causing severe distress or that are affecting everyday life. This includes sleep problems such as: Difficulty falling asleep Waking in the middle of the night Waking too early Stilnoct is not meant to be used every day for long periods of time. Ask your doctor for advice if Прочитайте повний документ
Health Products Regulatory Authority 25 January 2019 CRN008QF8 Page 1 of 2 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Stilnoct 10mg Film-coated Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains: Zolpidem tartrate 10mg Excipient(s) with known effect Lactose monohydrate For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Film-coated tablet. _Product imported from the UK_ Oblong, white, scored tablet engraved ‘SN10’ on one side and plain on the other. 4 CLINICAL PARTICULARS As per PA0540/160/002 5 PHARMACOLOGICAL PROPERTIES As per PA0540/160/002 6 PHARMACEUTICAL PARTICULARS 6.1 LIST OF EXCIPIENTS Tablet core Lactose Monohydrate Microcrystalline cellulose Hypromellose Sodium starch glycollate Magnesium stearate Film coating Macrogol 400 Titanium dioxide (E171) Hypromellose Health Products Regulatory Authority 25 January 2019 CRN008QF8 Page 2 of 2 6.2 INCOMPATIBILITIES Not applicable. 6.3 SHELF LIFE The shelf life expiry date of this product shall be the date shown on the container and outer package of the product on the market in the country of origin. 6.4 SPECIAL PRECAUTIONS FOR STORAGE Store in a dry place in the original packaging. Do not store above 30ºC. 6.5 NATURE AND CONTENTS OF CONTAINER PVC/foil blister strips in a cardboard outer carton. Pack size 28 tablets. 6.6 SPECIAL PRECAUTIONS FOR DISPOSAL OF A USED MEDICINAL PRODUCT OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCT AND OTHER HANDLING OF THE PRODUCT No special requirements. 7 PARALLEL PRODUCT AUTHORISATION HOLDER Imbat Limited Unit L2 North Ring Business Park Santry Dublin 9 Ireland 8 PARALLEL PRODUCT AUTHORISATION NUMBER PPA1151/030/001 9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 04 May 2007 Date of last renewal: 04 May 2012 10 DATE OF REVISION OF THE TEXT April 2018 Прочитайте повний документ